Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries

International Journal of Cancer

Volumn 123, Issue 10, 2008, Pages 2390-2396

  Chuang, Shu Chun ^a,b   Scelo, Ghislaine ^a   Tonita, Jon M ^c   Tamaro, Sharon ^d   Jonasson, Jon G ^e,f   Kliewer, Erich V ^g,h   Hemminki, Kari ^i,j   Weiderpass, Elisabete ^j,k,l   Pukkala, Eero ^m   Tracey, Elizabeth ⁿ   Friis, Soren ^o   Pompe Kirn, Vera ^p   Brewster, David H ^q   Martos, Carmen ^r   Chia, Kee Seng ^s,t   Boffetta, Paolo ^a   Brennan, Paul ^a   Hashibe, Mia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SASKATCHEWAN CANCER AGENCY   (Canada)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e ICELANDIC CANCER REGISTRY   (Iceland)

^f UNIVERSITY OF ICELAND   (Iceland)

^g Epidemiology and Cancer Registry   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j KAROLINSKA INSTITUTE   (Sweden)

^k CANCER REGISTRY OF NORWAY   (Norway)

^l FOLKHÄLSAN RESEARCH CENTER   (Finland)

^m FINNISH CANCER REGISTRY   (Finland)

ⁿ New South Wales Cancer Registry   (Australia)

^o INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^p INSTITUTE OF ONCOLOGY   (Slovenia)

^q INFORMATION SERVICES DIVISION   (United Kingdom)

^r Cancer Registry of Zaragoza   (Spain)

^s Centre for Molecular Epidemiology   (Singapore)

^t Singapore Cancer Registry   (Singapore)

more..

Author keywords

Head and neck cancer; Second cancer

Indexed keywords

ALCOHOL;

ANALYTIC METHOD; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; DATA ANALYSIS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; LUNG CANCER; MALE; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER; SMOKING; AGED; CLINICAL TRIAL; HEAD AND NECK TUMOR; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; REGISTER; SURVIVAL RATE;

AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 53449091246     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23798     Document Type: Article

References (34)

1. Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003;14 (Suppl 5):v61-v118.
2. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer 1998;34:2154-61.
3. Ogden GR. Second malignant tumours in head and neck cancer. BMJ 1991;302:193-94.
4. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343-53.
5. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21:204-10.
6. Giefing M, Rydzanicz M, Szukala K, Wozniak A, Wierzbicka M, Szyfter K, Kujawski M. Second primary tumors (SPT) of head and neck: distinguishing of ''true'' SPT from micrometastasis by LOH analysis of selected chromosome regions. Neoplasma 2005;52:374-80.
7. Ferlay J, Bray F, Pisani P, Parkin DM. Globcan 2002: Cancer incidence, mortality, and prevalence worldwide. IARC Cancer Base No. 5(2). Lyon, France: IARC Press, 2004.
8. Boice JD, Jr., Storm HH, Curtis RE, Jensen OM, Kleinerman RA, Jensen HS, Flannery JT, Fraumeni JF, Jr. Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 1985;68:3-9.
9. Veli EM, Schatzkin A. Common environmental risk factors. In: Neugut AI, Meadows AT, Robinson E, eds. Multiple primary cancers. Philadelphia: Lippincott Williams & Wilkins, 1999. 213-23.
10. Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006;15:2020-26.
11. Scelo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Andersen A, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, et al. Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 2006;118:189-96.
12. Brennan P, Scelo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, et al. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005;93:159-66.
13. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. (8). Lyon: IARC, 2002.
14. Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer epidemiology and prevention, third edition. New York: Oxford University Press, Inc, 2006. 674-96.
15. Scelo G, Boffetta P, Corbex M, Chia KS, Hemminki K, Friis S, Pukkala E, Weiderpass E, McBride ML, Tracey E, Brewster DH, Pompe-Kirn V, et al. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control 2007;18:269-78.
16. Muir CS, Percy C. Classification and coding for neoplasms. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, eds. Cancer registration: principles and methods. Lyon: IARC, 1991. 64-81.
17. IARC Working Group. Tobacco smoke and involuntary smoking. IARC 2004;83:1-1438.
18. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006;7:149-56.
19. Vaamonde P, Martin C, del Rio M, LaBella T. Second primary malignancies in patients with cancer of the head and neck. Otolaryngol Head Neck Surg 2003;129:65-70.
20. Dhooge IJ, De Vos M, Van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998;108:250-56.
21. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995;104:946-54.
22. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992;101:105-12.
23. Slaughter DP, Southwick HW, Smejakl W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-68.
24. Tomek MS, McGuirt WF. Second head and neck cancers and tobacco usage. Am J Otolaryngol 2003;24:24-27.
25. Castigliano SG. Influence of continued smoking on the incidence of second primary cancers involving mouth, pharynx, and larynx. J Am Dent Assoc 1968;77:580-85.
26. Goldstein DP, Irish JC. Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolaryngol Head Neck Surg 2005;13:207-11.
27. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol 2001;37:401-18.
28. Verschuur HP, Irish JC, O'Sullivan B, Goh C, Gullane PJ, Pintilie M. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope 1999;109:249-58.
29. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-35.
30. El Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003;27:1463-70.
31. Rose Ragin CC, Taioli E. Second primary head and neck tumor risk in patients with cervical cancer - SEER data analysis. Head Neck 2008;30:58-66.
32. Frisch M, Biggar RJ. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 1999;354:1442-43.
33. Braakhuis BJ, Tabor MP, Leemans CR, van dW, I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002;24:198-206.
34. Begg CB, Zhang ZF, Sun M, Herr HW, Schantz SP. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the surveillance, epidemiology, and end results (SEER) program. Am J Epidemiol 1995;142:653-65.